Wendy Dixon, Director at Incyte, holds 17.77K shares in Incyte (Ticker: INCY), holds ― shares in Voyager Therapeutics (Ticker: VYGR), holds 38.05K shares in Black Diamond Therapeutics (Ticker: BDTX).
Wendy Dixon latest transaction was an Uninformative Buy of $19.78K.
What was Wendy Dixon's most profitable transaction?
Wendy Dixon’s most profitable transaction was an Informative Buy of ALKS stock on March 13, 2014. The return on the trade was 46.60%.
What is Wendy Dixon's role in Incyte?
Wendy Dixon's role in Incyte is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.